Clark, D W <br/><br/>
Genetically determined variability in acetylation and oxidation. Therapeutic implications.  [electronic resource] 

 -  Drugs  Apr 1985 
 - 342-75 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0012-6667 
<br/><br/><label>Standard No.: </label>10.2165/00003495-198529040-00003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylation<br/>Anticonvulsants--metabolism<br/>Antidepressive Agents, Tricyclic--metabolism<br/>Debrisoquin--metabolism<br/>Disease--metabolism<br/>Drug Interactions<br/>Genetic Variation<br/>Humans<br/>Hydralazine--metabolism<br/>Isoniazid--metabolism<br/>Oxidation-Reduction<br/>Pharmaceutical Preparations--metabolism<br/>Phenelzine--metabolism<br/>Phenotype<br/>Procainamide--metabolism<br/>Racial Groups<br/>Sparteine--metabolism<br/>Sulfasalazine--metabolism